ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0740

Card9 Promotes Th17-mediated Arthritis and Spondylitis via Control of Acute Pathogenic Neutrophil Responses in SKG Mice

Holly Rosenzweig1, Emily Vance1, Ellen Lee1 and Ruth Napier1, 1Oregon Health & Science University and VA Portland Health Care System, Portland, OR

Meeting: ACR Convergence 2020

Keywords: Animal Model, Ankylosing spondylitis (AS), neutrophils, rheumatoid arthritis, TH17 Cells

  • Tweet
  • Email
  • Print
Session Information

Date: Saturday, November 7, 2020

Title: RA – Animal Models Poster

Session Type: Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Caspase recruitment domain-containing protein 9 (CARD9) is an intracellular signal transduction molecule that mediates antimicrobial responses following activation of C-type lectin receptors (ie. Dectin-1) by fungal ligands including β -glucans (zymosan). CARD9-deficient patients have defects in Th17 immunity and succumb to systemic candidiasis, and single nucleotide polymorphisms in CARD9 have been associated with susceptibility to Th17-mediated autoimmune diseases including ankylosing spondylitis. However, how dysregulation of CARD9 may regulate autoimmunity remains unknown. Here we sought to investigate the role of CARD9 in arthritis and spondylitis (spinal inflammation) as modeled in SKG mice.

Methods: Arthritis was induced in SKG vs. Card9-/- SKG mice by intraperitoneal injection of 1.5mg β-glucan (zymosan) and evaluated clinically for 8 weeks, by near-infrared imaging, and histologically. CD4+ T cells from draining lymph nodes were stimulated in vitro with PMA/ionomycin and Th effector subsets were quantified by intracellular cytokine staining and flow cytometry. For lavage studies, peritoneal fluid collected 4h post-zymosan was analyzed for immune cellular composition by flow cytometry and ELISA. Neutrophils were depleted in SKG mice with anti-Ly6G (1A8) or isotype control (2A3) beginning 24h prior to zymosan and every 2 d for 5 d. For all studies, three independent experiments were performed (n=5-6 mice/genotype), and data analyzed using non-parametric statistics.

Results: In stark contrast to SKG mice that developed chronic arthritis and features of spondylitis by 8 weeks post zymosan, Card9-/-SKG mice were completely protected from both diseases. Cell composition analysis of the ankle-draining lymph nodes at both 5 d and 8 wk post-zymosan revealed reduced numbers of neutrophils and effector Th17 responses in Card9-/-SKG mice. CARD9 promoted acute (pre-arthritic) neutrophil responses in SKG mice as Card9-/-SKG mice had reduced numbers of neutrophils, but not dendritic cells or macrophages, in lavage fluid as early as 4 h post-zymosan. Furthermore, neutrophils from Card9-/-SKG lavage fluid had similar surface expression of Dectin-1 to neutrophils from SKG mice, yet had decreased activation status (retention of CD62L) and reduced degranulation of primary (CD63) and secondary (CD66b) granules. These data suggest that Card9 may function downstream of Dectin-1 ligation to promote activation and degranulation of neutrophils. Akin to Card9-/-SKG mice, neutrophil-deplete SKG mice had delayed onset of arthritis and decreased Th17 responses 5 d post-zymosan, supporting a pathogenic function for early neutrophil responses in induction of arthritis. Cumulatively, these data support an integral role for Card9 in regulation of early neutrophil responses that promote Th17 cells and induction of arthritis.

Conclusion: These data show a direct link between Card9 signaling and neutrophil-intrinsic induction of autoreactive Th17 responses in arthritis. Further investigation of how Card9 functions within neutrophils to drive autoimmunity may serve to unveil novel therapeutic avenues for human Th17-mediated diseases including ankylosing spondylitis.


Disclosure: H. Rosenzweig, None; E. Vance, None; E. Lee, None; R. Napier, None.

To cite this abstract in AMA style:

Rosenzweig H, Vance E, Lee E, Napier R. Card9 Promotes Th17-mediated Arthritis and Spondylitis via Control of Acute Pathogenic Neutrophil Responses in SKG Mice [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/card9-promotes-th17-mediated-arthritis-and-spondylitis-via-control-of-acute-pathogenic-neutrophil-responses-in-skg-mice/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/card9-promotes-th17-mediated-arthritis-and-spondylitis-via-control-of-acute-pathogenic-neutrophil-responses-in-skg-mice/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology